Source: Annual Congress 2002 - Pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Amsha, T. E. Siddons, I. Armstrong, J. C. Waterhouse, D. Fishwick, T. W. Higenbottam, D. G. Kiely (Sheffield, United Kingdom). Effects of sildenafil on incremental shuttle walking test and haemodynamics in patients with pulmonary hypertension. Eur Respir J 2002; 20: Suppl. 38, 2311

Member's Comments

No comment yet.

Related content which might interest you: Long-term treatment with oral sildenafil in addition to chronic prostacyclin therapy improves pulmonary hemodynamics and six minute walking test in patients with pulmonary arterial hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 598s Year: 2002 The incremental shuttle walk test in pulmonary hypertension Source: International Congress 2019 – Exercise tolerance and its determinants across pathologies Year: 2019 The incremental shuttle walking test safely assesses exercise capacity in pulmonary hypertension Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004 Pulmonary hemodynamics during an intermittent exercise test in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 405s Year: 2003 Effect of treatment on exercise endurance tolerance and ventilatory efficiency in patients with pulmonary arterial hypertension (PAH) Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Percent-predicted incremental shuttle walking test distance stratifies risk in pulmonary arterial hypertension Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Value of maximal and submaximal variables during incremental cardiopulmonary exercise testing to predict survival in pateints with pulmonary arterial hypertension (PAH) Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Hemodynamics as a substitute for exercise capacity endpoints in patients with pulmonary arterial hypertension (PAH): A model based assessment for sildenafil Source: Annual Congress 2010 - Present and future medical management of pulmonary arterial hypertension Year: 2010 Relationship between sit-to-stand test and six-minute walk test in patients with pulmonary arterial hypertension Source: International Congress 2015 – The challenge of choosing the best physical and functional assessment methods Year: 2015 Incremental shuttle walking test distance predicts poor prognosis in pulmonary hypertension Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004 Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension Source: Eur Respir J 2012; 40: 1410-1419 Year: 2012 Maximal cardiopulmonary exercise testing in mildly symptomatic patients with idiopathic pulmonary arterial hypertension: correlations with 6-min walk distance and resting hemodynamics Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise Source: Eur Respir J 2001; 18: Suppl. 33, 324s Year: 2001 Repeatability of incremental shuttle and 6 minute walk test in pulmonary hypertension Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009 Comparison of three walking tests to cardiopulmonary exercise tests in the assessment of exercise tolerance in individuals with pulmonary arterial hypertension Source: International Congress 2016 – Physiotherapy interventions and assessment options in hospitalised patients Year: 2016 Long-term bosentan therapy improves exercise capacity and hemodynamics in sarcoidosis-associated pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments Year: 2012 Cardiopulmonary exercise testing, six minute walk and hemodynamics in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 Spiroveloergometry and 6-minute walking test for exercise capacity assessment in patients with primary pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 16s Year: 2005 Incremental shuttle walking test distance is reduced in patients with pulmonary hypertension in WHO Functional Class I Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise Year: 2018 Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension Source: Eur Respir J 2008; 32: 393-398 Year: 2008